Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook

Psychotherapy and Psychiatry Visits in the United States: A Cross-Sectional Study of MEPS, 2017-2019

Michael E. Johansen, MD, MS; Kelsey Sicker, MD

Corresponding Author: Michael Johansen, MD, MS; OhioHealth - Grant Family Medicine.

Contact Email: mikejoha3@gmail.com

Section: Brief Report

Publication Date: TBD

BACKGROUND: Rates of individuals with a psychotherapy visit has not been well studied and recent reports lack granularity by age.

METHODS: The 2017-2019 Medical Expenditure Panel Survey (MEPS) was used to investigate rates and associations of psychotherapy and psychiatry visits by age/sex and anti-depressant/anti-psychotic use.

RESULTS: The study included all 90,853 individuals, of which 5.2% (95%CI:4.9-5.4) reported any psychotherapy (excluding psychiatry visits) visit during a year, while 3.6% (95%CI:3.4-3.8) reported a visit with a psychiatrist. Females were more likely to have a psychotherapy visit than males after 15 years of age. The highest rates of females with a psychotherapy visit were between 15 and 30 years of age, while rates amongst males were highest between 10-25 years of age. For psychiatry visits, males had higher rates than females during pre-teen years, similar rates through teen years, lower rates though adulthood, and similar rates after 60 years of age. Rates of a psychiatry visit did not vary as much by age as a psychotherapy visit. Among anti-depressant or anti-psychotic medication users, the rate of either a psychotherapy visit or a psychiatry visit during a year was markedly higher at younger ages and decreased as age advanced.

CONCLUSION: Psychotherapy and psychiatry utilization have differences in population level patterns with use being highest amongst females between 15-30 years of age and higher amongst younger (compared to older) individuals who reported anti-depressants or anti-psychotics.

ABSTRACTS IN PRESS

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us

© 2022 American Board of Family Medicine

Powered by HighWire